Screener
Beta Bionics BBNX Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Research and development | 10,240 | 8,873 | 20,596 | 16,463 |
| Sales and marketing | 24,640 | 15,623 | 45,375 | 29,025 |
| General and administrative | 9,600 | 7,879 | 19,217 | 14,500 |
| Total operating expenses | 44,480 | 32,375 | 85,188 | 59,988 |
| Loss from operations | (25,578) | (19,872) | (49,849) | (38,514) |
| Other income (expense): | ||||
| Interest income | 2,177 | 3,005 | 4,553 | 5,441 |
| Other expense | (2) | (2) | (2) | (2) |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's total operating expenses?
- Beta Bionics (BBNX) reported total operating expenses of $44.48M in Q2 2026.
- How has Beta Bionics's total operating expenses changed year-over-year?
- Beta Bionics's total operating expenses increased by 37.4% year-over-year, from $32.38M to $44.48M.
- What is the long-term trend for Beta Bionics's total operating expenses?
- Over 2 years (2023 to 2025), Beta Bionics's total operating expenses has grown at a 73.7% compound annual growth rate (CAGR), from $42.16M to $127.22M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Beta Bionics's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude